These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 24669286)

  • 1. Early onset Alzheimer's disease and oxidative stress.
    Meraz-Ríos MA; Franco-Bocanegra D; Toral Rios D; Campos-Peña V
    Oxid Med Cell Longev; 2014; 2014():375968. PubMed ID: 24669286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty Years of Presenilins--Important Proteins in Health and Disease.
    Walter J
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S41-8. PubMed ID: 26605647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
    Oakley H; Cole SL; Logan S; Maus E; Shao P; Craft J; Guillozet-Bongaarts A; Ohno M; Disterhoft J; Van Eldik L; Berry R; Vassar R
    J Neurosci; 2006 Oct; 26(40):10129-40. PubMed ID: 17021169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.
    Gómez-Isla T; Growdon WB; McNamara MJ; Nochlin D; Bird TD; Arango JC; Lopera F; Kosik KS; Lantos PL; Cairns NJ; Hyman BT
    Brain; 1999 Sep; 122 ( Pt 9)():1709-19. PubMed ID: 10468510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms.
    Czech C; Tremp G; Pradier L
    Prog Neurobiol; 2000 Mar; 60(4):363-84. PubMed ID: 10670705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
    Jiang H; Niu F; Zheng Y; Xu Y
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurobiology and pharmacotherapy of Alzheimer's disease.
    Felician O; Sandson TA
    J Neuropsychiatry Clin Neurosci; 1999; 11(1):19-31. PubMed ID: 9990552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic Ozone Exposure Induces Gender-Dependent Neuropathology and Memory Decline in an Animal Model of Alzheimer's Disease.
    Akhter H; Ballinger C; Liu N; van Groen T; Postlethwait EM; Liu RM
    Toxicol Sci; 2015 Sep; 147(1):222-34. PubMed ID: 26116027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mouse models for APP processing and Alzheimer's disease: early and late defects.
    van Dooren T; Dewachter I; Borghgraef P; van Leuven F
    Subcell Biochem; 2005; 38():45-63. PubMed ID: 15709472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
    Crews L; Rockenstein E; Masliah E
    Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders.
    Mold MJ; O'Farrell A; Morris B; Exley C
    J Alzheimers Dis; 2020; 78(1):139-149. PubMed ID: 32925074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
    Ashrafian H; Zadeh EH; Khan RH
    Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental models of Alzheimer's disease for deciphering the pathogenesis and therapeutic screening (Review).
    Li X; Bao X; Wang R
    Int J Mol Med; 2016 Feb; 37(2):271-83. PubMed ID: 26676932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models of Alzheimer's disease: a quest for plaques and tangles.
    Richardson JA; Burns DK
    ILAR J; 2002; 43(2):89-99. PubMed ID: 11917160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological aspects and anti-amyloid strategy for Alzheimer's dementia.
    Liščić RM
    Arh Hig Rada Toksikol; 2013 Dec; 64(4):603-8. PubMed ID: 24384767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic animals in Alzheimer's disease research.
    Sturchler-Pierrat C; Sommer B
    Rev Neurosci; 1999; 10(1):15-24. PubMed ID: 10356989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.
    Oddo S; Caccamo A; Shepherd JD; Murphy MP; Golde TE; Kayed R; Metherate R; Mattson MP; Akbari Y; LaFerla FM
    Neuron; 2003 Jul; 39(3):409-21. PubMed ID: 12895417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.